Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) CEO Parth Mehrotra sold 12,219 shares of the business’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $225,073.98. Following the sale, the chief executive officer now directly owns 261,640 shares of […]
Privia Health Group, Inc. (NASDAQ:PRVA – Get Free Report) EVP Thomas Bartrum sold 2,252 shares of the business’s stock in a transaction dated Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total transaction of $41,481.84. Following the sale, the executive vice president now owns 103,862 shares in the […]
Handelsbanken Fonder AB increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 41.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 15,000 shares of the company’s stock after buying an additional 4,400 shares during the quarter. Handelsbanken Fonder AB’s holdings in Privia Health Group were worth $345,000 as […]
Citigroup started coverage on shares of Privia Health Group (NASDAQ:PRVA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The brokerage issued a buy rating and a $25.00 target price on the stock. A number of other analysts also recently issued reports on PRVA. JPMorgan Chase & Co. lowered their […]
Privia Health Group (NASDAQ:PRVA – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $38.00 to $30.00 in a research report released on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other equities analysts also recently issued reports on PRVA. Truist Financial […]